These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 27061705)

  • 1. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device.
    Lima B; Kale P; Gonzalez-Stawinski GV; Kuiper JJ; Carey S; Hall SA
    Am J Cardiol; 2016 May; 117(10):1622-1628. PubMed ID: 27061705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group.
    Fried J; Farr M; Kanwar M; Uriel N; Hernandez-Montfort J; Blumer V; Li S; Sinha SS; Garan AR; Li B; Hall S; Hickey GW; Mahr C; Nathan S; Schwartzman A; Kim J; Ton VK; Vishnevsky OA; Vorovich E; Abraham J; Zweck E; Guglin M; Vallabhajosyula S; Kataria R; Walec KD; Zazzali P; Kong Q; Sangal P; Burkhoff D; Kapur NK
    J Heart Lung Transplant; 2024 Sep; 43(9):1478-1488. PubMed ID: 38834162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Paradigm in Mechanical Circulatory Support: 100-Patient Experience.
    Chung JS; Emerson D; Ramzy D; Akhmerov A; Megna D; Esmailian F; Kobashigawa J; Cole RM; Moriguchi J; Trento A
    Ann Thorac Surg; 2020 May; 109(5):1370-1377. PubMed ID: 31563492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation.
    Cheng R; Tank R; Ramzy D; Azarbal B; Chung J; Esmailian F; Kobashigawa JA; Moriguchi JD; Arabia FA
    ASAIO J; 2019; 65(7):642-648. PubMed ID: 30281541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of children implanted with ventricular assist devices in the United States: First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS).
    Blume ED; Rosenthal DN; Rossano JW; Baldwin JT; Eghtesady P; Morales DL; Cantor RS; Conway J; Lorts A; Almond CS; Naftel DC; Kirklin JK;
    J Heart Lung Transplant; 2016 May; 35(5):578-84. PubMed ID: 27009673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.
    Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M
    Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Extracorporeal Continuous-Flow Ventricular Assist System for Patients With Advanced Heart Failure　- Initial Clinical Experience.
    Seguchi O; Fujita T; Kitahata N; Iwasaki K; Kuroda K; Nakajima S; Watanabe T; Yanase M; Fukushima S; Tsukiya T; Katagiri N; Mizuno T; Takewa Y; Hamasaki T; Onda K; Hayashi T; Yamamoto H; Tatsumi E; Kobayashi J; Fukushima N
    Circ J; 2020 Jun; 84(7):1090-1096. PubMed ID: 32461539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?
    Bartfay SE; Dellgren G; Lidén H; Holmberg M; Gäbel J; Redfors B; Bech-Hanssen O; Karason K
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):360-367.e1. PubMed ID: 27955912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained Use of the Impella 5.0 Heart Pump Enables Bridge to Clinical Decisions in 34 Patients.
    Nelson DW; Sundararajan S; Klein E; Joyce LD; Durham LA; Joyce DL; Mohammed AA
    Tex Heart Inst J; 2021 Jul; 48(3):. PubMed ID: 34388239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure.
    Hall SA; Uriel N; Carey SA; Edens M; Gong G; Esposito M; O'Kelly R; Annamalai S; Aghili N; Adatya S; Kapur NK
    J Heart Lung Transplant; 2018 Jan; 37(1):100-106. PubMed ID: 29056460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes.
    Shehab S; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Robson D; Newton PJ; Rao S; Wang L; Allida S; Connellan M; Granger E; Dhital K; Spratt P; Jansz PC; Hayward CS
    J Heart Lung Transplant; 2016 Apr; 35(4):466-73. PubMed ID: 26849954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre.
    Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V
    Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.